Last 12 months
Inside the activity.
2 purchase rows · 38 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 16 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 1 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2023 Filed Jun 12, 2023 21:41 UTC |
Larsen-Becker Brenda JaneDirector
|
GrantCommon Stock | 15,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 3 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,679 F4 · shares: Reflects a grant of RSUs made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of Common Stock. The number of RSUs granted is equal to approximately $120,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Read SEC document |
| June 08, 2023 Filed Jul 3, 2023 22:04 UTC |
Mazzacco CatherineDirector
|
GrantCommon Stock | 30,189 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016838 · doc4.xml · nonDerivative · entry 1 Mazzacco Catherine · CIK 0001967722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $240,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest in substantially equal installments on each of June 8, 2024, 2025, and 2026, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date. Read SEC document |
| June 08, 2023 Filed Nov 16, 2023 22:35 UTC Amendment |
Encrantz StaffanDirector · 10% owner
|
GrantCommon Stock | 15,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-064579 · ownership.xml · nonDerivative · entry 2 Encrantz Staffan · CIK 0001870875 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,034 F2 · shares: Reflects a grant of RSUs made to the Reporting Person under the Program. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Issuer's board of directors through such vesting date. Read SEC document |
| June 08, 2023 Filed Nov 16, 2023 22:35 UTC Amendment |
Encrantz StaffanDirector · 10% owner
|
GrantCommon Stock | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-064579 · ownership.xml · nonDerivative · entry 1 Encrantz Staffan · CIK 0001870875 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,940 F1 · shares: Reflects the vesting in full of 11,940 restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program (the "Program"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). Read SEC document |
| May 09, 2023 Filed May 12, 2023 01:55 UTC |
Bauerlein AlisonSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 71,800 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0000899243-23-012788 · doc4.xml · derivative · entry 2 Bauerlein Alison · CIK 0001596080 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,800 Underlying: Common Stock · 71,800 shares Expires 2033-05-09 F2 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable as to 25% of the underlying shares on April 3, 2024, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on April 3, 2027. F2 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable as to 25% of the underlying shares on April 3, 2024, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on April 3, 2027. Read SEC document |
| May 09, 2023 Filed May 12, 2023 01:55 UTC |
Bauerlein AlisonSee Remarks
|
GrantCommon Stock | 103,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-012788 · doc4.xml · nonDerivative · entry 1 Bauerlein Alison · CIK 0001596080 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments commencing May 15, 2024 and continuing through May 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs have no expiration date. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 06:15 UTC |
Park Sam BoongChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 69,100 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0000899243-23-009243 · doc4.xml · derivative · entry 2 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,100 Underlying: Common Stock · 69,100 shares Expires 2033-03-16 F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 06:15 UTC |
Park Sam BoongChief Operating Officer
|
GrantCommon Stock | 54,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-009243 · doc4.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,424 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i). Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 10:15 UTC |
Badawi PaulDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 225,700 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0000899243-23-009244 · doc4.xml · derivative · entry 2 Badawi Paul · CIK 0001870865 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,700 Underlying: Common Stock · 225,700 shares Expires 2033-03-16 F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 10:15 UTC |
Badawi PaulDirector · President and CEO
|
GrantCommon Stock | 176,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-009244 · doc4.xml · nonDerivative · entry 1 Badawi Paul · CIK 0001870865 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,278,481 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i). Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 10:15 UTC |
HAYDEN JEREMY B.Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 57,700 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0000899243-23-009245 · doc4.xml · derivative · entry 2 HAYDEN JEREMY B. · CIK 0001650737 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,700 Underlying: Common Stock · 57,700 shares Expires 2033-03-16 F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 10:15 UTC |
HAYDEN JEREMY B.Chief Legal Officer
|
GrantCommon Stock | 45,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-009245 · doc4.xml · nonDerivative · entry 1 HAYDEN JEREMY B. · CIK 0001650737 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,808 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i). Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 10:15 UTC |
Badawi DavidDirector · Chief Technology Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0000899243-23-009242 · doc4.xml · derivative · entry 2 Badawi David · CIK 0001870825 · Director · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-03-16 F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 10:15 UTC |
Badawi DavidDirector · Chief Technology Officer
|
GrantCommon Stock | 39,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-009242 · doc4.xml · nonDerivative · entry 1 Badawi David · CIK 0001870825 · Director · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,485,790 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i). Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 10:15 UTC |
Rodberg JamesSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 14,400 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0000899243-23-009241 · doc4.xml · derivative · entry 2 Rodberg James · CIK 0001961970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,400 Underlying: Common Stock · 14,400 shares Expires 2033-03-16 F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 10:15 UTC |
Rodberg JamesSee Remarks
|
GrantCommon Stock | 20,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-009241 · doc4.xml · nonDerivative · entry 1 Rodberg James · CIK 0001961970 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 699 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i). Read SEC document |
| March 15, 2023 Filed Jun 12, 2023 21:41 UTC |
Larsen-Becker Brenda JaneDirector
|
Tax withholdingCommon Stock | 2,295 | $9.08 | $20,845.49 |
DisclosureSEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 2 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,679 F2 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of the RSUs underlying the 2022 RSU Grant. F3 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2023 Filed Jun 12, 2023 21:41 UTC |
Larsen-Becker Brenda JaneDirector
|
GrantCommon Stock | 17,923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 1 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,974 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on March 15, 2022 under the Issuer's Non-Employee Director Compensation Program (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on March 18, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, one-third vested on March 15, 2023, and an additional one-third vests on each of March 15, 2024 and March 15, 2025, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date. Read SEC document |
| January 08, 2023 Filed Jan 10, 2023 23:43 UTC |
Fountain TamaraDirector
|
GrantCommon Stock | 17,977 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001508 · doc4.xml · nonDerivative · entry 1 Fountain Tamara · CIK 0001902243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on under the Issuer's 2021 Incentive Award Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest and become exercisable in substantially equal installments on each of January 1, 2024, 2025, and 2026, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 06:30 UTC |
Park Sam BoongChief Operating Officer
|
Tax withholdingCommon Stock | 2,393 | $12.38 | $29,622.95 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 5 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,424 F6 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs. F7 · price: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 11:30 UTC |
Badawi PaulDirector · President and CEO
|
Tax withholdingCommon Stock | 8,251 | $12.21 | $100,744.71 |
DisclosureSEC source: 0000899243-23-000826 · doc4.xml · nonDerivative · entry 2 Badawi Paul · CIK 0001870865 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,278,481 F3 · shares: Reflects shares of Common Stock withheld by the Issuer to cover the Reporting Person's tax liability in connection with the vesting of RSUs. F4 · price: Reflects the closing sale price of the Issuer's Common Stock as reported on The Nasdaq Global Select Market on December 30, 2022. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 11:30 UTC |
Selnick JesseChief Financial Officer
|
Tax withholdingCommon Stock | 2,891 | $12.38 | $35,787.69 |
DisclosureSEC source: 0000899243-23-000829 · doc4.xml · nonDerivative · entry 2 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,359 F3 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs. F4 · price: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 11:30 UTC |
Badawi DavidDirector · Chief Technology Officer
|
Tax withholdingCommon Stock | 2,431 | $12.21 | $29,682.51 |
DisclosureSEC source: 0000899243-23-000828 · doc4.xml · nonDerivative · entry 2 Badawi David · CIK 0001870825 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,485,790 F3 · shares: Reflects shares of Common Stock withheld by the Issuer to cover the Reporting Person's tax liability in connection with the vesting of RSUs. F4 · price: Reflects the closing sale price of the Issuer's Common Stock as reported on The Nasdaq Global Select Market on December 30, 2022. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 11:30 UTC |
HAYDEN JEREMY B.Chief Legal Officer
|
Tax withholdingCommon Stock | 1,192 | $12.38 | $14,755.77 |
DisclosureSEC source: 0000899243-23-000825 · doc4.xml · nonDerivative · entry 2 HAYDEN JEREMY B. · CIK 0001650737 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,808 F3 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs. F4 · price: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 06:30 UTC |
Park Sam BoongChief Operating Officer
|
GrantCommon Stock | 24,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 4 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,817 F4 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date. F5 · balance_after: Includes 6,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 11:30 UTC |
Badawi PaulDirector · President and CEO
|
GrantCommon Stock | 87,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000826 · doc4.xml · nonDerivative · entry 1 Badawi Paul · CIK 0001870865 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,286,732 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date. F2 · balance_after: Includes 21,950 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 11:30 UTC |
Selnick JesseChief Financial Officer
|
GrantCommon Stock | 28,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000829 · doc4.xml · nonDerivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,250 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date. F2 · balance_after: Includes 7,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 11:30 UTC |
Badawi DavidDirector · Chief Technology Officer
|
GrantCommon Stock | 28,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000828 · doc4.xml · nonDerivative · entry 1 Badawi David · CIK 0001870825 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488,221 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date. F2 · balance_after: Includes 7,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 11:30 UTC |
HAYDEN JEREMY B.Chief Legal Officer
|
GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000825 · doc4.xml · nonDerivative · entry 1 HAYDEN JEREMY B. · CIK 0001650737 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date. F2 · balance_after: Includes 3,000 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant. Read SEC document |
| November 18, 2022 Filed Jan 5, 2023 06:30 UTC |
Park Sam BoongChief Operating Officer
|
GrantCommon Stock | 3,128 | $6.79 | $21,245.38 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 3 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,792 F3 · shares: Reflects shares purchased under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:05 UTC |
Badawi DavidDirector · Chief Technology Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0000899243-22-031869 · doc4.xml · derivative · entry 2 Badawi David · CIK 0001870825 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2027-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested and exercisable. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:05 UTC |
Badawi DavidDirector · Chief Technology Officer
|
Exercise / conversionCommon Stock | 40,000 | $0.23 | $9,200.00 |
DisclosureSEC source: 0000899243-22-031869 · doc4.xml · nonDerivative · entry 1 Badawi David · CIK 0001870825 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,481,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2022 Filed Dec 30, 2025 21:11 UTC Amendment |
Badawi DavidDirector · Chief Technology Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001193125-25-337097 · ownership.xml · derivative · entry 2 Badawi David · CIK 0001870825 · Director · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,540 Underlying: Common Stock · 40,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The grant of stock options ("Options") made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on January 1, 2020. F3 · derivative.expiration_date: The original Form 4 filing identified the expiration date of the relevant Options as 01/08/2027. This amendment corrects the expiration date of the relevant Options to February 28, 2026. F1 · balance_after: Includes 1,441,196 shares that were previously reported as beneficially owned on the Reporting Person's Form 3 filed on July 14, 2021, as well as 7,460 shares that were acquired by the Reporting Person upon exercise of options prior to the Issuer's completion of the Initial Public Offering in July 2021 that should have been included under Column 2 of Table I of the Form 3 but were inadvertently included as shares underlying options with an exercise price of $0.23 that expire on February 28, 2026 under Column 3 of Table II of the Form 3. F4 · balance_after: Excludes the 7,460 shares that were previously inadvertently included as described in footnote (1) to this Form 4. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 21:43 UTC |
Hicks Mack H.Director · 10% owner
HEP Partners LLC10% owner
HH Sight LLC10% owner
HH Sight Partners GP, L.P.10% owner
HH Sight Partners, L.P.10% owner
HH-IOP Partners, L.P.10% owner
HICKS THOMAS O10% owner
|
OtherCommon Stock | 1,717,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-025869 · doc4.xml · nonDerivative · entry 2 Hicks Mack H. · CIK 0001413224 · Director · 10% owner HEP Partners LLC · CIK 0001810192 · 10% owner HH Sight LLC · CIK 0001872481 · 10% owner HH Sight Partners GP, L.P. · CIK 0001872472 · 10% owner HH Sight Partners, L.P. · CIK 0001667542 · 10% owner HH-IOP Partners, L.P. · CIK 0001667541 · 10% owner HICKS THOMAS O · CIK 0000938201 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F7 · kind: Represents a pro rata distribution in-kind of all the shares formerly held by HH-IOP to its partners (the "HH-IOP Distribution"). As a result of both the HH Sight Distribution and the HH-IOP Distribution, in addition to HH Sight Partners, each of HH-IOP, the GP, the GP of the GP, HEP and Thomas O. Hicks will no longer be a reporting person. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Mack H. Hicks, Thomas O. Hicks, HH Sight Partners, HH-IOP Partners, L.P. ("HH-IOP"), HH Sight Partners GP, L.P. (the "GP"), HH Sight LLC (the "GP of GP"), and HEP Partners LLC ("HEP"). HH Sight Partners, HH-IOP, and Mack H. Hicks (individually, as Trustee of the MHH 2016 Descendants Trust, and as the ultimate owner and control person of MHH Ventures Ltd.) are the direct beneficial owners of the securities covered by this statement. F3 · ownership.nature: The GP is the general partner of, and may be deemed to beneficially own securities owned by, each of HH Sight Partners and HH-IOP. The GP of the GP is the general partner of, and may be deemed to beneficially own securities owned by, the GP. Mack H. Hicks and Thomas O. Hicks are the co-managers of, and may each be deemed to beneficially own securities owned by, the GP of the GP. HEP is the investment manager of, and may be deemed to beneficially own securities owned by, each of HH Sight Partners and HH-IOP. Thomas O. Hicks is the Chairman, President, and Chief Executive Officer of, and may be deemed to beneficially own securities owned by, HEP. F4 · ownership.nature: Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities. F5 · ownership.nature: Each reporting person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. F8 · ownership.nature: Represents common stock directly held by HH-IOP. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 21:43 UTC |
Hicks Mack H.Director · 10% owner
HEP Partners LLC10% owner
HH Sight LLC10% owner
HH Sight Partners GP, L.P.10% owner
HH Sight Partners, L.P.10% owner
HH-IOP Partners, L.P.10% owner
HICKS THOMAS O10% owner
|
OtherCommon Stock | 2,669,530 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-025869 · doc4.xml · nonDerivative · entry 1 Hicks Mack H. · CIK 0001413224 · Director · 10% owner HEP Partners LLC · CIK 0001810192 · 10% owner HH Sight LLC · CIK 0001872481 · 10% owner HH Sight Partners GP, L.P. · CIK 0001872472 · 10% owner HH Sight Partners, L.P. · CIK 0001667542 · 10% owner HH-IOP Partners, L.P. · CIK 0001667541 · 10% owner HICKS THOMAS O · CIK 0000938201 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: Represents a pro rata distribution in-kind of all the shares formerly held by HH Sight Partners, L.P. ("HH Sight Partners") to its partners (the "HH Sight Distribution"). As a result of the HH Sight Distribution, HH Sight Partners will no longer be a reporting person. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Mack H. Hicks, Thomas O. Hicks, HH Sight Partners, HH-IOP Partners, L.P. ("HH-IOP"), HH Sight Partners GP, L.P. (the "GP"), HH Sight LLC (the "GP of GP"), and HEP Partners LLC ("HEP"). HH Sight Partners, HH-IOP, and Mack H. Hicks (individually, as Trustee of the MHH 2016 Descendants Trust, and as the ultimate owner and control person of MHH Ventures Ltd.) are the direct beneficial owners of the securities covered by this statement. F3 · ownership.nature: The GP is the general partner of, and may be deemed to beneficially own securities owned by, each of HH Sight Partners and HH-IOP. The GP of the GP is the general partner of, and may be deemed to beneficially own securities owned by, the GP. Mack H. Hicks and Thomas O. Hicks are the co-managers of, and may each be deemed to beneficially own securities owned by, the GP of the GP. HEP is the investment manager of, and may be deemed to beneficially own securities owned by, each of HH Sight Partners and HH-IOP. Thomas O. Hicks is the Chairman, President, and Chief Executive Officer of, and may be deemed to beneficially own securities owned by, HEP. F4 · ownership.nature: Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities. F5 · ownership.nature: Each reporting person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. F6 · ownership.nature: Represents common stock directly held by HH Sight Partners. Read SEC document |
| June 08, 2022 Filed Aug 5, 2022 20:14 UTC |
Encrantz StaffanDirector
|
GrantRestricted Stock Units · Derivative | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-027828 · doc4.xml · derivative · entry 1 Encrantz Staffan · CIK 0001870875 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. Read SEC document |
| June 08, 2022 Filed Aug 5, 2022 20:11 UTC |
Zurbay DonaldDirector
|
GrantRestricted Stock Units · Derivative | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-027823 · doc4.xml · derivative · entry 1 Zurbay Donald · CIK 0001341608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.. The RSUs have no expiration date. Read SEC document |
| June 08, 2022 Filed Aug 5, 2022 20:11 UTC |
Hicks Mack H.Director · 10% owner
|
GrantRestricted Stock Units · Derivative | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-027824 · doc4.xml · derivative · entry 1 Hicks Mack H. · CIK 0001413224 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. Read SEC document |
| June 08, 2022 Filed Aug 5, 2022 20:08 UTC |
Rogers Erica J.Director
|
GrantRestricted Stock Units · Derivative | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-027818 · doc4.xml · derivative · entry 1 Rogers Erica J. · CIK 0001769940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. Read SEC document |
| June 08, 2022 Filed Aug 5, 2022 20:12 UTC |
Schroeder ValeskaDirector
|
GrantRestricted Stock Units · Derivative | 11,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-027825 · doc4.xml · derivative · entry 1 Schroeder Valeska · CIK 0001870428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,940 Underlying: Common Stock · 11,940 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest on the earlier of (i) June 8, 2023 and (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date. The RSUs have no expiration date. Read SEC document |
| May 17, 2022 Filed May 18, 2022 01:40 UTC |
Encrantz StaffanDirector · 10% owner
|
PurchaseCommon Stock | 250,000 | $8.49 | $2,123,725.00 |
DisclosureSEC source: 0000899243-22-018500 · doc4.xml · nonDerivative · entry 3 Encrantz Staffan · CIK 0001870875 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 551,802 F2 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4) and (5). F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.155 to $8.73 per share, inclusive. F3 · ownership.nature: These shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 16, 2022 Filed May 18, 2022 01:40 UTC |
Encrantz StaffanDirector · 10% owner
|
PurchaseCommon Stock | 300,000 | $8.20 | $2,460,000.00 |
DisclosureSEC source: 0000899243-22-018500 · doc4.xml · nonDerivative · entry 2 Encrantz Staffan · CIK 0001870875 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 301,802 F2 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4) and (5). F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.025 to $8.45 per share, inclusive. F3 · ownership.nature: These shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 13, 2022 Filed May 18, 2022 01:40 UTC |
Encrantz StaffanDirector · 10% owner
|
PurchaseCommon Stock | 1,802 | $7.98 | $14,381.94 |
DisclosureSEC source: 0000899243-22-018500 · doc4.xml · nonDerivative · entry 1 Encrantz Staffan · CIK 0001870875 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,802 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00 per share, inclusive. F2 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4) and (5). F3 · ownership.nature: These shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:05 UTC |
Selnick JesseChief Financial Officer
|
PurchaseCommon Stock | 5,000 | $8.28 | $41,400.00 |
DisclosureSEC source: 0000899243-22-018389 · doc4.xml · nonDerivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,225 F1 · ownership.direct: The Reporting Person previously reported indirect beneficial ownership of 2,219,568 shares of Common Stock held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). Sight Sciences Angels subsequently distributed such shares of Common Stock to its partners, resulting in the Reporting Person directly owning the shares of Common Stock in which he previously had an indirect pecuniary interest. Such change in ownership was exempt from reporting pursuant to Rule 16a-13. Read SEC document |
| May 11, 2022 Filed May 23, 2022 21:44 UTC |
Selnick JesseChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0000899243-22-019270 · doc4.xml · derivative · entry 4 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 30,000 shares Expires 2029-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments beginning on March 18, 2019. Read SEC document |
| May 11, 2022 Filed May 23, 2022 21:44 UTC |
Selnick JesseChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0000899243-22-019270 · doc4.xml · derivative · entry 3 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares on January 23, 2019 and in 36 equal monthly installments thereafter. Read SEC document |
| May 11, 2022 Filed May 23, 2022 21:44 UTC |
Selnick JesseChief Financial Officer
|
Exercise / conversionCommon Stock | 30,000 | $0.62 | $18,600.00 |
DisclosureSEC source: 0000899243-22-019270 · doc4.xml · nonDerivative · entry 2 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,000 shares acquired on May 13, 2022 reported on a Form 4 filed on May 17, 2022. Read SEC document |
| May 11, 2022 Filed May 23, 2022 21:44 UTC |
Selnick JesseChief Financial Officer
|
Exercise / conversionCommon Stock | 120,000 | $0.35 | $42,000.00 |
DisclosureSEC source: 0000899243-22-019270 · doc4.xml · nonDerivative · entry 1 Selnick Jesse · CIK 0001870424 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,000 shares acquired on May 13, 2022 reported on a Form 4 filed on May 17, 2022. Read SEC document |
| March 25, 2022 Filed Jan 5, 2023 06:30 UTC |
Park Sam BoongChief Operating Officer
|
Exercise / conversionCommon Stock | 3,666 | $1.96 | $7,185.36 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 2 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. Read SEC document |
| March 15, 2022 Filed Mar 18, 2022 21:47 UTC |
Larsen-Becker Brenda JaneDirector
|
GrantRestricted Stock Units · Derivative | 17,923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011607 · doc4.xml · derivative · entry 1 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,923 Underlying: Common Stock · 17,923 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest in three substantially equal annual installments beginning on March 15, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest in three substantially equal annual installments beginning on March 15, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date. The RSUs have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.